CAS: 267243-28-7 - Canertinib
Formula:C23H23ClFN5O3
InChI:InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)
InChI key:InChIKey=OMZCMEYTWSXEPZ-UHFFFAOYSA-N
SMILES:O=C(C=C)NC1=CC=2C(=NC=NC2NC3=CC=C(F)C(Cl)=C3)C=C1OCCCN4CCOCC4
- Synonyms:
- 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-
- 4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propyloxy]-6-[(vinylcarbonyl)amino]quinazoline
- Canertinib base
- Cl 1033
- N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide
- N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide
- N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[2-(morpholin-4-yl)ethoxy]quinazolin-6-yl}prop-2-enamide
- N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Canertinib REF: IN-DA00BCK6CAS: 267243-28-7 | 98% | To inquire | Tue 07 Jan 25 | |
Canertinib REF: 7W-GW7411CAS: 267243-28-7 | - - - | 143.00 €~194.00 € | Mon 13 Jan 25 | |
Canertinib REF: TM-T6136CAS: 267243-28-7 | 100% - 99.18% | 37.00 €~86.00 € | Mon 13 Jan 25 | |
Canertinib REF: 10-F863395CAS: 267243-28-7 | 98% | To inquire | Thu 16 Jan 25 | |
Canertinib REF: TR-C175600CAS: 267243-28-7 | - - - | - - - | Discontinued product | |
Canertinib (CI-1033) REF: 3D-SKA24328CAS: 267243-28-7 | Min. 95% | - - - | Discontinued product |
Canertinib
CAS:267243-28-7
Formula:
C24H25ClFN5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
485.9384
Ref: IN-DA00BCK6
1g | To inquire | ||
10mg | 74.00 € | ||
50mg | 152.00 € | ||
100mg | 267.00 € | ||
250mg | 583.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 7W-GW7411
1mg | 143.00 € | ||
5mg | 182.00 € | ||
10mg | 194.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Canertinib
CAS:267243-28-7
Canertinib (CI-1033), a pan-erbB inhibitor, effectively targets esophageal cancer in vitro/vivo, altering metabolism and reducing …
Formula:
C24H25ClFN5O3
Purity:
100% - 99.18%
Color and Shape:
White Or Similar To White Crystalline Powder
Molecular weight:
485.94
Ref: TM-T6136
5mg | 37.00 € | ||
10mg | 54.00 € | ||
25mg | 69.00 € | ||
50mg | 86.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 10-F863395
1g | To inquire | ||
10mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
Canertinib
CAS:267243-28-7
Applications Antineoplastic; irreversible pan-erbB tyrosine kinase inhibitor used to treat cancer. References Li, D., et …
Formula:
C24H25ClFN5O3
Color and Shape:
Pale Yellow Solid
Molecular weight:
485.94
Ref: TR-C175600
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |
Canertinib (CI-1033)
CAS:267243-28-7
Canertinib is a small molecule that inhibits the protein synthesis of cancer cells by inhibiting …
Formula:
C24H25ClFN5O3
Purity:
Min. 95%
Molecular weight:
485.94 g/mol
Ref: 3D-SKA24328
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |